Assisted Reproductive Technology Survey (ART Survey)
Sponsor
Pennington Biomedical Research Center (Other)
Overall Status
Completed
CT.gov ID
NCT02249390
Collaborator
(none)
336
1
31
10.8
Study Details
Study Description
Brief Summary
The purpose of the study is to collate local information to better understand the motivations, accessibility and frequency of assisted reproductive technology (ART) use in the community.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
The ART survey study recruitment will last about 6 months with the study completed within 1 year. Study participation is an online survey which takes approximately 3 minutes to complete.
The goal is to apply for future funding to study the metabolic consequences of being conceived with ART.
Study Design
Study Type:
Observational
Actual Enrollment
:
336 participants
Observational Model:
Ecologic or Community
Time Perspective:
Retrospective
Official Title:
ART Survey: Assisted Reproductive Technology Survey
Study Start Date
:
Sep 1, 2014
Actual Primary Completion Date
:
Apr 1, 2017
Actual Study Completion Date
:
Apr 1, 2017
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Anyone Any individual may complete this survey |
Outcome Measures
Primary Outcome Measures
- Method of Conception [1 year]
ART Survey
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- Any individual may complete this survey
Exclusion Criteria:
- No exclusion criteria
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Pennington Biomedical Research Center | Baton Rouge | Louisiana | United States | 70808 |
Sponsors and Collaborators
- Pennington Biomedical Research Center
Investigators
- Principal Investigator: Leanne M Redman, MS, PHD, Pennington Biomedical Research Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Leanne Redman,
Principal Investigator,
Pennington Biomedical Research Center
ClinicalTrials.gov Identifier:
NCT02249390
Other Study ID Numbers:
- PBRC 2014-042
First Posted:
Sep 25, 2014
Last Update Posted:
Jun 9, 2022
Last Verified:
Jun 1, 2022